SLA congratulates Roslin Cells on their recent success with TSB funding
Released: Thursday 23rd August 2012
SLA is delighted to see Roslin Cells secure over £125 K in funding from the Biocatalyst Feasibility Competition. Roslin Cells will use this to
|
improve the clinical utility of umbilical cord blood donations by Ex-Vivo Expansion using Mesenchymal Stromal Cells. For further details please contact aidan.courtney@roslincells.com |
